M Mlika, A Ayadi-Kddour, S Friaa-Meraï, A Marghli, T Kilani, F El Mezni
immunohistochemistry, lung, pathology, sclerosing haemangioma, surgical treatment, tuberculosis
M Mlika, A Ayadi-Kddour, S Friaa-Meraï, A Marghli, T Kilani, F El Mezni. The so called pulmonary sclerosing hemangioma. The Internet Journal of Pulmonary Medicine. 2008 Volume 11 Number 1.
The so called pulmonary sclerosing hemangioma (PSH) is a relatively rare benign tumour which was described initially in 1956 by Liebow and Hubell (1). It has been also called benign alveolar cell tumour and hamartoma (2, 3, 4). It is categorized as a miscellaneous tumour in the new 1999 World Health Organization (5). We report 2 new cases of PSH diagnosed based on histological and immunohistochemical findings.
A 60-year-old asymptomatic woman underwent in 1998 a chest roentogram for preoperative evaluation of a breast carcinoma. Chest-X-ray showed a peripheral, homogeneous and well-circumscribed nodule located in the right lung. The CT-scan revealed a lesion of the middle lobe. No lymphadenopathy was observed (Figure 1).
The diagnosis of a metastatic disease was initially suspected. A right middle lobectomy was undergone through a right postero-lateral thoracotomy. Per-operative findings consisted in a well circumscribed 2-centimeter nodule associated with multiple adenomegalies which were excised. Extemporaneous examination of the tumoral nodule didn’t allow to rule out a malignant lesion. Histological examination showed a well circumscribed but non encapsulated nodule measuring 2, 5 x 2 cm. Two patterns were predominantly observed: solid and papillary. Blood-filled spaces were also noted [Figure 2].
The solid pattern was composed of a sheet-like proliferation of round to polygonal cells with a pale cytoplasm. The papillary pattern was lined by cuboïdal surface cells. Whereas, polygonal cells appeared in the stroma. Polygonal cells, which lined the stroma, expressed the epithelial membrane antigen (EMA) and the thyroid transcription factor-1 (TTF-1). Cuboidal cells expressed EMA, TTF1 and cytokeratin [Figure 3].
CD34 and Desmin were also used and were negative in both types of cells. According to the histological and immunohistochemical findings, the diagnosis of PSH was retained. The patient didn’t present any recurrences after a ten-year follow up period.
The second patient is a 38-year old patient without a particular past medical history who presented with an unproductive cough, anorexia and asthenia. The onset of the symptoms was one month. A chest-x-ray showed 2 peripheral nodules. Pulmonary fibroscopy showed inflammatory lesions. A thoraco and abdominal CT-scan showed 2 peripheral nodules of the left lung. The 2 nodules showed a marked contrast enhancement. There were no adenomegalies. Multiple hepatic nodules corresponding to biliary cysts were also noted. In order to rule out a malignant disease, a postero-lateral thoracotomy was performed. Two nodules measuring 2 cm and an adenomegaly were discovered and resected. The extemporaneous examination concluded to a benign disease evoking tuberculosis because of the presence of many granulomas. Histological and immunohistochemical examination concluded to a PSH with a granulomatous reaction. Sputum cultures were negative for mycobacterium tuberculosis. Seven years after the establishment of the first diagnosis, the patient didn’t presented recurrences.
Although initially regarded as a variant of haemangioma, on the basis of the results of immunohistochemical and genetic studies PSH is now considered as an epithelial tumour. It is usually observed in women (80% of the cases) with a mean age of 16 years (range, 11 to 80 years) (8). Eighty percent of the patients are asymptomatic and the lesions are generally discovered incidentally (8). In symptomatic patients, that account for 10 to 20% of the cases, the cough, the dyspnea, the chest pain and hemoptysia are mainly observed. On chest-x-ray, these tumours appear as a well-defined round or oval masses like in our 2 cases (5). According to Im and coworkers, in a report of CT-findings in 8 cases, these tumours present as a well-defined juxta-pleural mass with marked contrast enhancement caused by its hemangiomatous component (9). This finding was observed in our second patient and these morphological features are characteristic enough to rule out a malignant nodule which is generally lobulated with speculated margins. However, these features can overlap with the CT-findings of other benign nodules such as hamartoma. Chung and colleagues stipulate that dynamic studies showing characteristic strong and early enhancement are indicators of PSH (5). Unusual manifestations include a mass tumour with a cystic appearance.
Different pathways seem to play a key role in the tumorigenesis of PSH.
PSH are benign tumours with a good behaviour. Although the progress made in radiological techniques to elucidate these lesions, the diagnosis remains based on histological findings. The treatment is surgical and no case of malignant transformation has been reported in the literature.